Programme

1st Day:

11:00 - 12:00 12:00 - 12:15





12:15 - 13:25
Chairs:
12:15
Keynote


12:45

13:05



Friday, 23rd September 2016

Registration & Coffee Welcome
Josef Glößl - Vice Rector for Research and International Research Collaboration, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria
N.N.
- to be announced

Tissue and Organ Replacement
Michael B. Fischer, Dirk Strunk
Rainer Marksteiner - Innovacell Biotechnologie AG, Innsbruck, Austria:
“Myoblasts in Clinical Trials - What Lessons Did We Learn About the Future of Cell Therapies?”
Michael Cross - University Hospital Leipzig, Germany:
“MSC for GvHD: Multicentre Trials and Tribulations”
Hannes Klump - University Hospital Essen, Germany:
“From Pluripotent to Hematopoietic Stem Cells – HOX Proteins Pave the Way”

13:25 - 14:15
Chair:

Coffee, Cake & Companies
Iris Ribitsch

14:15 - 15:30
Chairs:
14:15
Keynote


14:45



15:00



15:15



Musculoskeletal Research
Florien Jenner, Heinz Redl
Mari Dezawa - Tohoku University Graduate School of Medicine, Sendai, Japan:
“Unique Newly Discovered Muse Cells May Lead to the Paradigm Shift of Stem Cell Therapy”
Johannes Grillari - University of Natural Resources and Life Sciences (BOKU), Vienna, Austria:
“From Cellular Senescence to Circulating miRNA as Biomarkers in Bone Diseases”
Iris Ribitsch - VetmedUni Vienna, Austria:
“Repair Processes at the Protein Level - an Exploratory Whole-Proteome Profiling Approach to Follow up Tendon and Cartilage Healing”
Sylvia Nürnberger - LBI Trauma & Medical University Vienna, Austria:
“Scaffold Concepts for Cartilage Regeneration”

15:30 - 17:00
Chair:

Coffee & Posters I (P01 - P12)
Renate Kunert

17:00 - 18:40
Chairs:
17:00


17:20

17:40

18:00

18:20




Framework Issues
Michael Comer, Hermann Katinger
Hendrik Jan Ankersmit - Medical University of Vienna, Austria:
“Regulatory Affairs in Regenerative Medicine: the Perspective of a Drug Developer in Regenerative Medicine”
Peter Kampits - Danube University Krems, Austria:
“Transition of Stem Cells to the Clinic - Ethical Issues”
Martin Brunner - Medical University of Vienna, Austria:
“Clinical Studies with ATMPs - Practical Issues”
Ilona Reischl - AGES, Vienna, Austria:
“An Update on European Regulatory Activity and Experience”
Giancarlo Forte - FNUSA-ICRC/ St. Anne's University Hospital, Brno, Czech Republic:
“Investigating the Role of Mechanosensors in Cell Function and in Cardiac Diseases”

19:00

Dinner
Barbecue at the BOKU Campus

Programme

2nd Day:

09:00 - 10:30
Chairs:
09:00
Keynote

09:45
Keynote

Saturday, 24th September 2016

Cancer and Immunotherapy
Thomas Felzmann, Hannes Stockinger
Stanley R. Riddell - University of Washington & Fred Hutchinson Cancer Research Center, Washington, USA:
“Chimeric Antigen Receptor T Cells – Killing Cancer by Design”
Ulrich Jäger - Medical University of Vienna, Austria:
“CAR T-Cells: Clinical Application - Getting Started”

10:30 - 11:15
Chair:

Coffee & Posters II (P13 - P18)
Renate Kunert

11:15 - 13:00
Chair:
11:15
Keynote

12:00
Keynote

12:45


Cardiovascular Research
Johann Wojta
Georg Weitzer - Medical University of Vienna, Austria:
“Molecular Basis for the Temporary Activation of Endogenous Cardiac Stem Cells in the Diseased Heart”
Wolfram Zimmermann - University Medical Center Göttingen, Germany:
“Translation of Tissue Engineered Heart Repair”
Bernhard Haubner - Medical University of Innsbruck, Austria:
“Plasticity of Neonatal Hearts”

13:00 - 14:00
Chair:

Lunch & Posters III (P19 - P23)
Renate Kunert

14:00 - 15:20
Chairs:
14:00
Keynote

14:20


14:40



15:00



Clinical Trials with ATMPs
Beatrix Reinprecht, Ilona Reischl
Florian Göbel - Novartis Pharma GmbH, Vienna, Austria:
“How to Implement Innovation: Clinical Trials of CAR T-Cell Therapies in Austria”
Dirk Strunk - Paracelsus Medical University Salzburg, Austria:
“Lost in Translation: Which Stem Cells Can Be Used for What Application?”
René Geyeregger - St. Anna Childrens Cancer Research Institute, Vienna, Austria:
“The Challenging Way from Compassionate Use to Approved ATMP Study”
Elisabeth Mayr - EB-House, Salzburg, Austria:
“Ex Vivo Gene/Cell Therapy: From Named Patient Project to
Phase I/II Clinical Trial”

15:20 - End

Concluding Remarks & Discussion
Michael Comer - Chairman PACT